ZA201700939B - Computational analysis of biological data using manifold and a hyperplane - Google Patents

Computational analysis of biological data using manifold and a hyperplane

Info

Publication number
ZA201700939B
ZA201700939B ZA2017/00939A ZA201700939A ZA201700939B ZA 201700939 B ZA201700939 B ZA 201700939B ZA 2017/00939 A ZA2017/00939 A ZA 2017/00939A ZA 201700939 A ZA201700939 A ZA 201700939A ZA 201700939 B ZA201700939 B ZA 201700939B
Authority
ZA
South Africa
Prior art keywords
hyperplane
manifold
biological data
computational analysis
computational
Prior art date
Application number
ZA2017/00939A
Other languages
English (en)
Inventor
Eran Eden
Kfir Oved
Roy Navon
Assaf Cohen-Dotan
Olga Boico
Original Assignee
Memed Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memed Diagnostics Ltd filed Critical Memed Diagnostics Ltd
Publication of ZA201700939B publication Critical patent/ZA201700939B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20—Probabilistic models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Data Mining & Analysis (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Software Systems (AREA)
  • Immunology (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Probability & Statistics with Applications (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
ZA2017/00939A 2014-08-14 2017-02-07 Computational analysis of biological data using manifold and a hyperplane ZA201700939B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462037180P 2014-08-14 2014-08-14
US201562105938P 2015-01-21 2015-01-21
PCT/IL2015/050823 WO2016024278A1 (en) 2014-08-14 2015-08-12 Computational analysis of biological data using manifold and a hyperplane

Publications (1)

Publication Number Publication Date
ZA201700939B true ZA201700939B (en) 2021-05-26

Family

ID=55303939

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2017/00939A ZA201700939B (en) 2014-08-14 2017-02-07 Computational analysis of biological data using manifold and a hyperplane

Country Status (12)

Country Link
US (6) US10303846B2 (enExample)
EP (2) EP3699930B1 (enExample)
JP (2) JP6661607B2 (enExample)
KR (1) KR20170041907A (enExample)
CN (2) CN111624346A (enExample)
AU (2) AU2015302870B2 (enExample)
BR (1) BR112017002884A2 (enExample)
CA (2) CA2954601C (enExample)
IL (1) IL250585B (enExample)
RU (1) RU2730836C2 (enExample)
WO (1) WO2016024278A1 (enExample)
ZA (1) ZA201700939B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011132086A2 (en) 2010-04-21 2011-10-27 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
US11868851B2 (en) * 2015-03-11 2024-01-09 Symphonyai Sensa Llc Systems and methods for predicting outcomes using a prediction learning model
EP3414716A1 (en) * 2016-02-12 2018-12-19 Carrier Corporation Shelf life estimation system
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
WO2017149547A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
WO2017221255A1 (en) 2016-06-23 2017-12-28 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
CN109844532B (zh) * 2016-08-10 2022-06-17 米密德诊断学有限公司 分析生物数据的系统和方法
KR101739703B1 (ko) * 2016-09-13 2017-05-24 (주) 어드밴스드 엔티 Trail 기반 뇌염 감별진단 방법 및 장치
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
MX2019008257A (es) 2017-01-11 2019-10-07 Koninklijke Philips Nv Metodo y sistema para la deteccion automotizada de criterios de inclusion o exclusion.
EP3583568A4 (en) * 2017-02-17 2020-08-05 Accuweather Inc. SYSTEM AND METHOD FOR FORECASTING ECONOMIC TRENDS USING STATISTICAL ANALYSIS OF WEATHER DATA
US11335461B1 (en) * 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
DE112017007051B4 (de) * 2017-03-16 2022-04-14 Mitsubishi Electric Corporation Signalverarbeitungsvorrichtung
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US10474681B1 (en) * 2017-09-26 2019-11-12 Microsoft Technology Licensing, Llc Filtering mapped datasets
US11504071B2 (en) * 2018-04-10 2022-11-22 Hill-Rom Services, Inc. Patient risk assessment based on data from multiple sources in a healthcare facility
US11908581B2 (en) 2018-04-10 2024-02-20 Hill-Rom Services, Inc. Patient risk assessment based on data from multiple sources in a healthcare facility
WO2020036571A1 (en) 2018-08-16 2020-02-20 RICHARDSON, Paul, Stephen Systems and methods for automatic bias monitoring of cohort models and un-deployment of biased models
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
FR3088652A1 (fr) * 2018-11-21 2020-05-22 Nanotracks Diagnostics Détection in vitro de la présence d’au moins un agent pathogène microbien dans un échantillon biologique
CA3127569A1 (en) * 2019-02-18 2020-08-27 The University Of Liverpool Method of diagnosis
CN113711319A (zh) * 2019-03-12 2021-11-26 诺华股份有限公司 用于区分哮喘与copd的数字解决方案
US11104946B2 (en) * 2019-04-23 2021-08-31 Inflammatix, Inc. DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome
US11238129B2 (en) * 2019-12-11 2022-02-01 International Business Machines Corporation Root cause analysis using Granger causality
WO2021152595A1 (en) 2020-01-29 2021-08-05 Memed Diagnostics Ltd. Methods of diagnosing and classifying viral infections
CN111816297A (zh) * 2020-03-31 2020-10-23 复旦大学附属中山医院 一种基于云端的nCoV病毒诊疗系统和方法
WO2022004730A1 (ja) * 2020-06-30 2022-01-06 株式会社堀場製作所 体液分析装置、体液検体を判定するための方法、および、コンピュータープログラム
CN111657961B (zh) * 2020-07-03 2021-04-27 北京印刷学院 一种在皮肤上制备超表面用于血糖检测的方法
JP2023145811A (ja) * 2020-08-17 2023-10-12 孝章 赤池 学習モデルの生成方法、プログラム、演算装置
CN112185583B (zh) * 2020-10-14 2022-05-31 天津之以科技有限公司 一种基于贝叶斯网络的数据挖掘检疫方法
US11430575B2 (en) * 2020-11-13 2022-08-30 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for a data driven disease test result prediction
CN112632151B (zh) * 2020-12-25 2023-02-10 南京邮电大学 一种基于二分过滤的移动对象传染行为挖掘方法
US11361847B1 (en) 2021-02-06 2022-06-14 Timothy A. Hodge System and method for rapidly reporting testing results
WO2023023125A1 (en) * 2021-08-17 2023-02-23 Predigen, Inc. Methods for characterizing infections and methods for developing tests for the same
CN114818833A (zh) * 2022-05-27 2022-07-29 北京市商汤科技开发有限公司 心率测量方法、装置、电子设备、存储介质和程序产品
WO2025015221A1 (en) * 2023-07-12 2025-01-16 Bukowski Radek Interactive platform for assisting with medical decision-making
CN120689546B (zh) * 2025-05-07 2026-02-06 中国科学院空间应用工程与技术中心 一种基于点阵结构的三维建模方法及系统

Family Cites Families (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4230767A (en) 1978-02-08 1980-10-28 Toyo Boseki Kabushiki Kaisha Heat sealable laminated propylene polymer packaging material
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5018067A (en) 1987-01-12 1991-05-21 Iameter Incorporated Apparatus and method for improved estimation of health resource consumption through use of diagnostic and/or procedure grouping and severity of illness indicators
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5910421A (en) 1995-12-21 1999-06-08 University Of Florida Rapid diagnostic method for distinguishing allergies and infections
US6077665A (en) 1996-05-07 2000-06-20 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in neonates
US7026446B1 (en) 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
AU762756B2 (en) 1998-05-18 2003-07-03 Apoptosis Technology, Inc. Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
DE60032150T2 (de) 1999-08-24 2007-09-27 Glycozym Aps Udp-n-acetylglucosamin: galaktose-beta 1,3-n-acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3
IL132687A0 (en) * 1999-11-01 2001-03-19 Keren Mechkarim Ichilov Pnimit System and method for evaluating body fluid samples
US20020038227A1 (en) 2000-02-25 2002-03-28 Fey Christopher T. Method for centralized health data management
US7668661B2 (en) 2000-04-28 2010-02-23 Siemens Healthcare Diagnostics Inc. Liver disease-related methods and systems
WO2002007064A2 (en) * 2000-07-17 2002-01-24 Labnetics, Inc. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US20020055176A1 (en) * 2000-11-08 2002-05-09 Ray Robert A. Diagnostic assay system
WO2002077281A1 (fr) 2001-03-27 2002-10-03 Kabushiki Kaisha Toshiba Procede de detection d'acide nucleique relatif a une maladie
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE10119804A1 (de) 2001-04-23 2002-10-24 Brahms Ag Entzündungsspezifische Peptide und deren Verwendungen
KR100932577B1 (ko) * 2001-05-18 2009-12-17 기린 홀딩스 가부시키가이샤 항 ｔｒａｉｌ-ｒ 항체
FI115165B (fi) 2001-06-04 2005-03-15 Aboatech Ab Oy Menetelmä infektion laadun määrittämiseksi
DE10130985B4 (de) 2001-06-27 2004-03-18 B.R.A.H.M.S Ag Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente
US20040209307A1 (en) 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
DE50103907D1 (de) 2001-12-07 2004-11-04 Brahms Ag Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
EP1317902B1 (en) 2001-12-10 2005-11-09 Kabushiki Gaisha K-and-S Biological data observation apparatus
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
US7468032B2 (en) 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US20040122296A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management for triaging health-related data
CN1656378A (zh) 2002-03-22 2005-08-17 协和美帝克斯股份有限公司 诊断病毒感染的方法
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
JP2005529599A (ja) 2002-06-11 2005-10-06 アイダホ リサーチ ファウンデーション ウィルス感染を検出するためのタイプｉインターフェロン誘導タンパク質
BR0315935A (pt) * 2002-10-31 2005-09-20 Health Research Inc Teste de diagnóstico para o vìrus do nilo ocidental
US8563476B2 (en) 2002-11-15 2013-10-22 Morehouse School Of Medicine Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
AU2004245998A1 (en) 2003-06-04 2004-12-16 The Government of the United States as represented by The Secretary of the Department of Health and Human Services, Centres for Disease Control and Prevention PNI microarray and uses
JP2007518062A (ja) 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
GB0401730D0 (en) 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US8906630B2 (en) 2004-02-27 2014-12-09 The Trustees Of The University Of Pennsylvania Assays for detecting pathogenic respiratory bacteria
US7892539B2 (en) 2004-03-24 2011-02-22 The Regents Of The University Of California Modulation of an innate immune response by altering TRIAL-R signaling
US8155993B2 (en) * 2004-06-15 2012-04-10 Janssen Pharmaceutica, N.V. Apparatus and methods for assessing a pharmaceutical product
EP1787128A2 (en) * 2004-07-09 2007-05-23 Amaox, Inc. Immune cell biosensors and methods of using same
WO2006023312A2 (en) * 2004-08-20 2006-03-02 Carl Deirmengian Diagnostic assay for source of inflammation
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
EP1805500A4 (en) * 2004-09-28 2008-05-07 Singulex Inc SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES
AU2005334466B2 (en) 2004-11-05 2011-05-26 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Diagnosis and prognosis of infectious disease clinical phenotypes and other physiologic states using host gene expression biomarkers in blood
US20060099628A1 (en) 2004-11-10 2006-05-11 Wei-Mei Ching Diagnostic assay for rickettsia prowazekii disease by detection of responsive gene expression
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
CN101208602A (zh) 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
US20070015172A1 (en) 2005-06-01 2007-01-18 Z-Biomed, Inc. Expression profiles for microbial infection
UA78641C2 (en) 2005-08-29 2007-04-10 Open Joint Stock Company Conce A process for the preparation of carbamide-formaldehyde resin
DE102005050933A1 (de) 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
CN101378764A (zh) 2005-12-09 2009-03-04 贝勒研究院 通过血液白细胞微阵列分析对系统性红斑狼疮的诊断、预后和疾病发展的监测
GB0601959D0 (en) 2006-01-31 2006-03-15 King S College London Sepsis test
US20070184460A1 (en) 2006-02-09 2007-08-09 Wei-Mei Ching Diagnostic assay for Orientia tsutsugamushi by detection of responsive gene expression
KR20090023360A (ko) 2006-04-26 2009-03-04 버텍스 파마슈티칼스 인코포레이티드 Ｃ형 간염 바이러스 감염 바이오마커
RU2348695C2 (ru) * 2006-05-23 2009-03-10 Закрытое акционерное общество "Молекулярно-медицинские технологии" Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа
SG177956A1 (en) 2006-08-11 2012-02-28 Baylor Res Inst Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
US8026076B2 (en) 2006-09-05 2011-09-27 Hvidovre Hospital IP-10 based immunological monitoring
AU2012244350B2 (en) 2006-09-05 2013-08-15 Statens Serum Institut Ip-10 based immunological monitoring
US20100068147A1 (en) 2006-10-05 2010-03-18 Agency for Science , Technology and Research Dengue diagnosis and treatment
WO2008070135A2 (en) 2006-12-06 2008-06-12 Medimmune, Llc. Methods of treating systemic lupus erythematosus
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
WO2008076077A1 (en) 2006-12-21 2008-06-26 Innogene Kalbiotech Pte Ltd Method of early diagnosis of epstein-barr virus-related cancer and respective reagents and kits
US20100221700A1 (en) 2007-01-11 2010-09-02 Haynes Barton F Method of monitoring hiv infection
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
AU2008220419A1 (en) 2007-02-28 2008-09-04 The Procter & Gamble Company Methods and targets for identifying compounds for regulating rhinovirus infection
AU2008256216B2 (en) 2007-06-01 2014-07-31 Council Of Scientific & Industrial Research A novel method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
RU2352948C1 (ru) 2007-06-15 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "КРАСНОЯРСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Способ прогноза исхода заболевания пациентов с ургентной хирургической патологией органов брюшной полости
IL184478A (en) 2007-07-08 2017-07-31 Hadasit Medical Res Services & Development Ltd Preparations, methods and kits for identifying carriers of mutations in genes 1brca and 2brca and for the early detection of cancers associated with mutations in these genes
DE102007035640A1 (de) 2007-07-27 2009-01-29 Lkh-Kunststoffwerk Gmbh & Co. Kg Tauchkolben
EP2020603A1 (en) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
ATE533061T1 (de) 2007-08-03 2011-11-15 Brahms Gmbh Verfahren zur diagnose bakterieller infektionen
TW200920358A (en) 2007-08-13 2009-05-16 Lundbeck & Co As H Method of treating stress-mediated depression
WO2009025743A2 (en) 2007-08-17 2009-02-26 University Of Massachusetts Medical School Use of trail compositions as antiviral agents
DE502007003414D1 (de) 2007-09-24 2010-05-20 Bmdsys Production Gmbh Kryostat mit stabilisiertem Aussengefäss
EP2071334A1 (en) 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
WO2009100907A1 (en) 2008-02-14 2009-08-20 Dianeering Diagnostics Engineering And Research Gmbh Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers
US8293880B2 (en) * 2008-03-25 2012-10-23 University Of Southern California Prognostic panel for urinary bladder cancer
EP2271776A1 (en) 2008-04-21 2011-01-12 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Antiviral therapy
US9910036B2 (en) 2008-05-20 2018-03-06 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US8697370B2 (en) 2008-05-23 2014-04-15 Pronota N.V. Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
KR20110036590A (ko) 2008-06-25 2011-04-07 베일러 리서치 인스티튜트 결핵균 감염의 혈액 전사 시그너처
WO2010046136A1 (en) 2008-10-24 2010-04-29 B.R.A.H.M.S. Ag Prognosis and risk assessment in stroke patients by determining the level of marker peptides
US20160041153A1 (en) * 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
EP2350320A4 (en) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
TW201021778A (en) 2008-11-12 2010-06-16 Alcon Res Ltd Intraocular lens delivery device with a multi-part plunger tip
UA92843C2 (ru) 2009-05-21 2010-12-10 Институт Технической Теплофизики Национальной Академии Наук Украины Способ получения порошкообразного пищевого красителя из столовой свеклы
WO2011008349A2 (en) 2009-05-26 2011-01-20 Duke University Methods of identifying infectious disease and assays for identifying infectious disease
JP5731489B2 (ja) 2009-06-05 2015-06-10 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸困難を起こした患者における細菌感染の検出
WO2011017685A1 (en) 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney transplant rejection
JP5667353B2 (ja) * 2009-09-25 2015-02-12 シスメックス株式会社 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム
ES2601104T3 (es) 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio
CA2777800C (en) 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
AU2010328019A1 (en) 2009-12-09 2012-06-28 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
US20110312534A1 (en) * 2010-03-05 2011-12-22 Erasmus University Medical Center Rotterdam Method for prediction of human iris color
EP2365456B1 (en) * 2010-03-11 2016-07-20 CompuGroup Medical SE Data structure, method and system for predicting medical conditions
WO2011132086A2 (en) 2010-04-21 2011-10-27 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
US20130071866A1 (en) 2010-05-31 2013-03-21 The University Of Tokushima Method for testing the severtiy of an illness
GB2482187A (en) * 2010-07-23 2012-01-25 Univ Exeter Predicting response to surgery
US8877212B2 (en) 2011-02-07 2014-11-04 Trudeau Institute Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis
RU2476887C2 (ru) 2011-03-29 2013-02-27 Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения РАМН Способ прогнозирования развития осложнений у больных внебольничной пневмонией
WO2012176779A1 (ja) * 2011-06-20 2012-12-27 協和発酵キリン株式会社 抗ｅｒｂＢ３抗体
EP2756103A4 (en) 2011-09-12 2015-06-03 Univ Vanderbilt CHARACTERIZATION OF MULTIPLE SCLEROSIS
JP5842107B2 (ja) * 2011-10-19 2016-01-13 パナソニックＩｐマネジメント株式会社 循環動態測定装置
EP2592421B1 (en) 2011-11-14 2017-08-30 Universitätsklinikum Jena Diagnosis of sepsis and systemic inflammatory response syndrome
WO2013119632A1 (en) * 2012-02-07 2013-08-15 Ingber Michael Apparatus and methods for analyzing a medical condition
AU2013217935B2 (en) * 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN104159616B (zh) 2012-03-08 2017-10-31 托门医学股份公司 在牙科应用中用于诊断炎性组织的口香糖
EP2637023A1 (en) 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
EP2831264B1 (en) * 2012-03-30 2019-07-10 VisEn Medical, Inc. Bacterial imaging agents and methods of using same
GB201211982D0 (en) 2012-07-05 2012-08-22 Isis Innovation Biomarker
AU2013289854B2 (en) 2012-07-10 2016-03-24 Nepean Blue Mountains Local Health District Risk stratification in influenza
FR2996003B1 (fr) 2012-09-25 2014-10-17 Commissariat Energie Atomique Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active
US20140127827A1 (en) 2012-11-05 2014-05-08 Gwangju Institute Of Science And Technology Method for detection of antigen using fluorescence resonance energy transfer immunoassay
MX2015006757A (es) 2012-11-30 2015-11-30 Applied Proteomics Inc Método para la evaluación de la presencia de o riesgo de tumores de colon.
EP3608416A1 (en) 2013-01-22 2020-02-12 Imicroq, S.L. Rapid method for detection of pathogen
SG11201505852YA (en) * 2013-01-29 2015-08-28 Molecular Health Gmbh Systems and methods for clinical decision support
US10689701B2 (en) 2013-03-15 2020-06-23 Duke University Biomarkers for the molecular classification of bacterial infection
WO2014144029A2 (en) * 2013-03-15 2014-09-18 Boston Scientific Neuromodulation Corporation Clinical response data mapping
WO2015042465A1 (en) 2013-09-20 2015-03-26 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
WO2015048098A1 (en) 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
JP6788586B2 (ja) 2014-11-19 2020-11-25 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． Ｈｎｌを用いる診断方法
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
KR20160072626A (ko) 2014-12-15 2016-06-23 전북대학교산학협력단 패혈증 인자 il-6 간이 진단 키트
EP3367895A4 (en) * 2015-11-01 2019-07-03 Elminda Ltd. METHOD AND SYSTEM FOR CALCULATING THE POTENTIAL DISTRIBUTION ON A CORTICAL SURFACE
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
WO2017149547A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
WO2017221255A1 (en) 2016-06-23 2017-12-28 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018052137A1 (ja) 2016-09-16 2018-03-22 株式会社オンチップ・バイオテクノロジーズ 微粒子分注装置、微粒子解析装置、及び反応検出装置、並びにそれらを用いる方法
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US12348304B2 (en) 2021-04-08 2025-07-01 Infinidome Ltd. Adjustable null steering in a stationary network

Also Published As

Publication number Publication date
CN107076746A (zh) 2017-08-18
CA2954601A1 (en) 2016-02-18
WO2016024278A1 (en) 2016-02-18
JP2017532633A (ja) 2017-11-02
EP3699930A3 (en) 2020-10-28
IL250585B (en) 2020-10-29
JP6661607B2 (ja) 2020-03-11
RU2730836C2 (ru) 2020-08-26
US20250104800A1 (en) 2025-03-27
BR112017002884A2 (pt) 2018-01-30
US20170235871A1 (en) 2017-08-17
EP3699930B1 (en) 2024-02-07
JP7095001B2 (ja) 2022-07-04
CN111624346A (zh) 2020-09-04
EP3699930A2 (en) 2020-08-26
US20220399074A1 (en) 2022-12-15
US11081206B2 (en) 2021-08-03
EP3180621A1 (en) 2017-06-21
US20200388347A1 (en) 2020-12-10
JP2020113285A (ja) 2020-07-27
AU2015302870A1 (en) 2017-03-16
US11776658B2 (en) 2023-10-03
US20190237156A1 (en) 2019-08-01
KR20170041907A (ko) 2017-04-17
EP3180621A4 (en) 2018-04-18
US20240029818A1 (en) 2024-01-25
US10303846B2 (en) 2019-05-28
US11450406B2 (en) 2022-09-20
EP3180621B1 (en) 2020-04-01
CA3190715A1 (en) 2016-02-18
US12131807B2 (en) 2024-10-29
AU2022200802A1 (en) 2022-03-03
CN107076746B (zh) 2020-05-29
CA2954601C (en) 2023-04-18
IL250585A0 (en) 2017-04-30
RU2017107750A3 (enExample) 2019-01-22
RU2017107750A (ru) 2018-09-17
AU2015302870B2 (en) 2021-12-23

Similar Documents

Publication Publication Date Title
IL250585A0 (en) Computational analysis of biological data using sheet and plane
PL3171765T3 (pl) Zbieranie i analiza danych do celów diagnostycznych
GB2543728B (en) Medical kit and method for processing a biological sample
IL248022A0 (en) A method and device for ontological mapping
EP3091479A4 (en) Fingerprint identification method and fingerprint identification device
EP3230924A4 (en) Fingerprint sensing device
EP3189129A4 (en) Devices and methods for dissociating a biological tissue sample
SG11201608958TA (en) Workload automation and data lineage analysis
EP3152700A4 (en) Fingerprint sensing apparatus
EP3187107A4 (en) Biological information detection device
EP3199231A4 (en) Large reactor and device and process thereof
GB201411912D0 (en) Method of collecting computer user data
EP3187109A4 (en) Biological information detection device
GB201502033D0 (en) Methods and systems for analyzing healthcare data
EP3208752A4 (en) Data analysis method and data display method
EP4224807C0 (en) METHOD AND APPARATUS FOR DATA TRANSMISSION
EP3207865A4 (en) Biological information processing device and biological information processing method
EP3087194A4 (en) Devices and methods for processing a biological sample
DK3146479T3 (da) Rfid-tag-samling og kirurgisk instrument
GB201419814D0 (en) Data traffic processing and analysis
GB2550631B (en) Analysis device and analysis method
GB201401584D0 (en) Intelligent detection of biological entities
ZA201605760B (en) Immobilized proteins and use thereof
EP3239704A4 (en) Analysis data processing method and device
EP3237556C0 (en) MICROPARTICLES AND DEVICE FOR INTELLIGENT INK MANUFACTURING